UCB (EBR:UCB) UCB Media Room: Transparency notification FMR LLC
Directive transparence : information réglementée Communiqué sur comptes, résultats, chiffres d’affaires
18/03/2022 20:09
https://mb.cision.com/Public/18595/3527792/a7a6660117b62bed_800x800ar.png
** Transparency notification FMR LLC
------------------------------------------------------------
Brussels (Belgium), 18 March 2022 =E2=80=93 20:05 (CET) =E2=80=93 Regulated=
information=C2=A0
1.=C2=A0Summary of the notification
Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large =
shareholdings, UCB SA/NV announces that it has received a transparency noti=
fication from FMR LLC. (having its registered office at 245 Summer Street, =
Boston, Massachusetts, 02210, U.S.A.), on 16 March 2022.=C2=A0
FMR LLC., has notified that, following an acquisition of UCB shares with vo=
ting rights by its affiliates, its shareholding in UCB SA has increased and=
it has crossed the 5% threshold, on 14 March 2022.
On 14 March 2022, FMR LLC. (taking into account the holding of its affiliat=
es) owned 9 770 956 UCB shares with voting rights, representing 5.02% of th=
e total number of shares issued by the company (194 505 658), versus 4.98% =
(9 690 661 UCB shares) in the previous notification dated 31 January 2022.
2.=C2=A0=C2=A0Content of the notification
=C2=B7 Reason for the notification: Acquisition or disposal of voting secur=
ities or voting rights.=C2=A0
=C2=B7 Notification by: A parent undertaking or a controlling person.
=C2=B7 Persons subject to the notification requirement:=C2=A0
https://mb.cision.com/Public/18595/3527792/936af8dbed7ec89c_800x800ar.png
=C2=B7 Date on which the threshold is crossed: 14 March 2022.=C2=A0
=C2=B7 Threshold crossed (in %): 5%.
=C2=B7 Denominator: 194 505 658.
=C2=B7 Notified details:
https://mb.cision.com/Public/18595/3527792/b804d611bb14f697_800x800ar.png
=C2=B7 Chain of controlled undertakings through which the holding is effect=
ively held:
https://mb.cision.com/Public/18595/3527792/8554449271fc2268_800x800ar.png
3.=C2=A0Further information
This press release and the detailed transparency notification are available=
on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com=
/investors/UCB-shareholders/Transparency-notifications) .
An updated overview of the UCB SA/NV large shareholdings will be available =
on UCB SA/NV=E2=80=99s website via the following link (https://www.ucb.com/=
investors/UCB-shareholders) .
For further information, contact UCB:=C2=A0
Investor Relations
Antje Witte=C2=A0
T +32 2 559 94 14
antje.witte@ucb.com
Corporate Communications
Laurent Schots=C2=A0
T+32 2 559 92 64
laurent.schots@ucb.com =C2=A0=C2=A0 =C2=A0
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 600 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi=
llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news
=C2=A0
GenericFile
220318 PR Transparency notification FMR LLC (https://mb.cision.com/Public/1=
8595/3527792/85dab25de502a8f1.pdf) GenericFile
220318 - CdP Notification de transparence FMR LLC (https://mb.cision.com/Pu=
blic/18595/3527792/80a786ffcd00119a.pdf) GenericFile
220318 PB Transparantieverklaring FMR LLC (https://mb.cision.com/Public/185=
95/3527792/8515395ba53c0ab8.pdf) Image
Chart 1 March 18 2022 (https://mb.cision.com/Public/18595/3527792/936af8dbe=
d7ec89c_org.png) Image
Chart 2 March 18 2022 (https://mb.cision.com/Public/18595/3527792/b804d611b=
b14f697_org.png) Image
Chart 3 March 18 2022 (https://mb.cision.com/Public/18595/3527792/855444927=
1fc2268_org.png)
______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x99674x1x6868579x24000=
x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium
26/04/2024 20:00
25/04/2024 18:00
25/04/2024 07:01
23/04/2024 20:00
22/04/2024 07:01
19/04/2024 20:00
17/04/2024 07:01
12/04/2024 20:00
12/04/2024 18:01
12/04/2024 07:01